These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells. Pizzolla A; Wang Z; Groom JR; Kedzierska K; Brooks AG; Reading PC; Wakim LM Proc Natl Acad Sci U S A; 2017 May; 114(20):5225-5230. PubMed ID: 28461487 [TBL] [Abstract][Full Text] [Related]
8. Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge. Li Z; Zhang M; Zhou C; Zhao X; Iijima N; Frankel FR J Immunol; 2008 Feb; 180(4):2504-13. PubMed ID: 18250460 [TBL] [Abstract][Full Text] [Related]
9. Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses. Tan HX; Gilbertson BP; Jegaskanda S; Alcantara S; Amarasena T; Stambas J; McAuley JL; Kent SJ; De Rose R Vaccine; 2016 Feb; 34(9):1172-9. PubMed ID: 26826545 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines. Belyakov IM; Ahlers JD Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096 [TBL] [Abstract][Full Text] [Related]
11. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. Parr MB; Parr EL J Virol; 1998 Apr; 72(4):2677-85. PubMed ID: 9525585 [TBL] [Abstract][Full Text] [Related]
12. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Belyakov IM; Ahlers JD Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298 [TBL] [Abstract][Full Text] [Related]
14. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. Milligan GN; Bernstein DI; Bourne N J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526 [TBL] [Abstract][Full Text] [Related]
15. C5a receptor targeting of partial non-structural protein 3 of dengue virus promotes antigen-specific IFN-γ-producing T-cell responses in a mucosal dengue vaccine model. Kim SH; Kim YN; Kim J; Jang YS Cell Immunol; 2018 Mar; 325():41-47. PubMed ID: 29397905 [TBL] [Abstract][Full Text] [Related]
16. Cutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTOR. Sowell RT; Rogozinska M; Nelson CE; Vezys V; Marzo AL J Immunol; 2014 Sep; 193(5):2067-71. PubMed ID: 25070853 [TBL] [Abstract][Full Text] [Related]
17. Unique features of antiviral immune system of the vaginal mucosa. Kumamoto Y; Iwasaki A Curr Opin Immunol; 2012 Aug; 24(4):411-6. PubMed ID: 22673876 [TBL] [Abstract][Full Text] [Related]
18. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530 [TBL] [Abstract][Full Text] [Related]
19. Efficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization. Bivas-Benita M; Bar L; Gillard GO; Kaufman DR; Simmons NL; Hovav AH; Letvin NL J Virol; 2010 Jun; 84(11):5764-74. PubMed ID: 20335249 [TBL] [Abstract][Full Text] [Related]
20. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Mitchell EA; Bergmeier LA; Doyle C; Brookes R; Hussain LA; Wang Y; Lehner T Eur J Immunol; 1998 Oct; 28(10):3066-74. PubMed ID: 9808175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]